|
98
|
315
|
7mbfA |
Codeinone reductase isoform 1.3 apo form |
|
116
|
318
|
7ezlA |
Rice l-galactose dehydrogenase (holo form) |
|
111
|
323
|
7eziA |
Rice l-galactose dehydrogenase (apo form) |
|
80
|
326
|
7ej2A |
Human voltage-gated potassium channel kv1.3 h451n mutant |
|
83
|
326
|
7ej1A |
Human voltage-gated potassium channel kv1.3 |
|
104
|
316
|
6y03A |
Structure of human aldose reductase mutant l300/301a with a citrate molecule bound in the anion binding pocket |
|
103
|
316
|
6t27A |
Structure of human aldose reductase mutant l301a with a citrate molecule bound in the anion binding pocket |
|
126
|
503
|
7jtkI |
Radial spoke 1 isolated from chlamydomonas reinhardtii |
|
130
|
503
|
7jrjH |
Chlamydomonas reinhardtii radial spoke head and neck (recombinant) |
|
105
|
316
|
6t5gA |
Structure of human aldose reductase mutant l300a with a citrate molecule bound in the anion binding pocket |
|
104
|
316
|
6t7qA |
Human aldose reductase mutant l301a in complex with a ligand with an idd structure (3-({[2-(carboxymethoxy)-4-fluorobenzoyl]amino}methyl)benzoic acid) |
|
105
|
316
|
6t3pA |
Human aldose reductase mutant l300a in complex with a ligand with an idd structure ({5-fluoro-2-[(3-nitrobenzyl)carbamoyl]phenoxy}acetic acid) |
|
104
|
316
|
6td8A |
Human aldose reductase mutant l301a in complex with a ligand with an idd structure ({5-fluoro-2-[(3-nitrobenzyl)carbamoyl]phenoxy}acetic acid) |
|
101
|
313
|
6tucA |
Human aldose reductase in complex with alr25 |
|
104
|
316
|
6tufA |
Human aldose reductase in complex with alr43 |
|
104
|
316
|
6txpA |
Human aldose reductase mutant l300a in complex with a ligand with an idd structure (3-({[2-(carboxymethoxy)-4-fluorobenzoyl]amino}methyl)benzoic acid) |
|
114
|
314
|
6kblA |
Structure-function study of akr4c14, an aldo-keto reductase from thai jasmine rice (oryza sativa l. ssp. indica cv. kdml105) |
|
114
|
318
|
6m7kA |
Structure of mouse recon (akr1c13) in complex with cyclic amp-amp-gmp (caag) |
|
104
|
318
|
5z6uA |
Crystal strcuture of d-xylose reductase from scheffersomyces stipitis |
|
106
|
329
|
5zcmA |
Crystal structure of xylose reductase from debaryomyces nepalensis in complex with nadp-dtt adduct |
|
101
|
320
|
5zciA |
Crystal structure of apo form of xylose reductase from debaryomyces nepalensis |
|
108
|
317
|
5z6tA |
Crystal strcuture of d-xylose reductase from scheffersomyces stipitis in complex with nadph |
|
106
|
316
|
6f84A |
Akr1b1 at 2.55 mgy radiation dose. |
|
106
|
316
|
6f81A |
Akr1b1 at 0.75 mgy radiation dose. |
|
106
|
314
|
6f8oA |
Akr1b1 at 3.45 mgy radiation dose. |
|
108
|
316
|
6f7rA |
Akr1b1 at 0.03 mgy radiation dose. |
|
106
|
316
|
6f82A |
Akr1b1 at 1.65 mgy radiation dose. |
|
120
|
318
|
6gxkA |
Crystal structure of aldo-keto reductase 1c3 (akr1c3) complexed with inhibitor. |
|
89
|
316
|
5m2fX |
Crystal structure of human akr1b10 complexed with nadp+ and the synthetic retinoid uvi2008 |
|
96
|
316
|
5liwX |
Crystal structure of human akr1b10 complexed with nadp+ and the inhibitor mk319 |
|
96
|
316
|
5liyX |
Crystal structure of human akr1b10 complexed with nadp+ and the inhibitor mk204 |
|
93
|
316
|
5lixX |
Crystal structure of human akr1b10 complexed with nadp+ and the inhibitor mk184 |
|
96
|
328
|
5ketA |
Structure of the aldo-keto reductase from coptotermes gestroi |
|
93
|
283
|
5jh2A |
Crystal structure of the holo form of akr4c7 from maize |
|
98
|
283
|
5jh1A |
Crystal structure of the apo form of akr4c7 from maize |
|
117
|
318
|
5jm5A |
Crystal structure of akr1c3 complexed with a pro-drug |
|
99
|
314
|
5jgwA |
Crystal structure of maize akr4c13 in complex with nadp and acetate |
|
106
|
307
|
5jgyA |
Crystal structure of maize akr4c13 in p21 space group |
|
117
|
315
|
5hntA |
Crystal structure of akr1c3 complexed with cape |
|
118
|
318
|
6f78A |
Potent and selective aldo-keto reductase 1c3 (akr1c3) inhibitors based on the benzoisoxazole moiety: application of a bioisosteric scaffold hopping approach to flufenamic acid |
|
116
|
314
|
6f2uA |
Potent and selective aldo-keto reductase 1c3 (akr1c3) inhibitors based on the benzoisoxazole moiety: application of a bioisosteric scaffold hopping approach to flufenamic acid |
|
93
|
325
|
6ebkA |
The voltage-activated kv1.2-2.1 paddle chimera channel in lipid nanodiscs |
|
92
|
325
|
6eblA |
The voltage-activated kv1.2-2.1 paddle chimera channel in lipid nanodiscs, cytosolic domain |
|
95
|
284
|
6ciaA |
Crystal structure of aldo-keto reductase from klebsiella pneumoniae in complex with nadph. |
|
106
|
313
|
5y7nA |
Crystal structure of akr1b10 in complex with nadp+ and androst-4-ene-3-beta-6-alpha-diol |
|
107
|
281
|
5c7hA |
Crystal structure of aldo-keto reductase from sinorhizobium meliloti 1021 in complex with nadph |
|
118
|
315
|
4zfcA |
Crystal structure of akr1c3 complexed with glicazide |
|
114
|
319
|
4falA |
Crystal structure of human 17beta-hydroxysteroid dehydrogenase type 5 in complex with 3-((3,4-dihydroisoquinolin-2(1h)-yl)sulfonyl)-n-methylbenzamide (80) |
|
87
|
271
|
4exaA |
Crystal structure of the pa4992, the putative aldo-keto reductase from pseudomona aeruginosa |
|
110
|
282
|
4f40A |
X-ray crystal structure of apo prostaglandin f synthase from leishmania major friedlin |
